Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Recovery After Total Hip Arthroplasty
NCT07430228Phase 2Enrolling by invitation
- Sponsor
- Wake Forest University Health Sciences
- Start
- Dec 2026
- Primary completion
- Dec 2027
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin in total hip arthroplasty (THA), sponsored by Wake Forest University Health Sciences. Planned start Dec 2026; status: enrolling by invitation.
02
Drugs
oxytocin
03
Conditions
total hip arthroplasty (THA)
Beyond the preview
Go deeper on NCT07430228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07430228.